Paper7879983
Comparison of body surface area-based and weight-based dosage protocols for doxorubicin administration in dogs.
Arrington KA and 3 others. Am J Vet Res, 1994. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Comparison of body surface area-based and weight-based dosage protocols for doxorubicin administration in dogs. Papers, record 7879983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7879983
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of body surface area-based and weight-based dosage protocols for doxorubicin administration in dogs.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dogs | Major topic |
| Doxorubicin | Major topic |
| Animals | |
| Blood Cell Count | |
| Body Surface Area | |
| Body Weight | |
| Dose-Response Relationship, Drug | |
| Female | |
| Leukocyte Count | |
| Male | |
| Neutrophils | |
| Platelet Count |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41910421 | Adverse events in small dogs treated with a single dose of vinblastine. | J Vet Intern Med | 2026 | https://conductscience.org/library/papers/41910421 | PubMed |
| 41900948 | Comparative Cancer Genetics and Veterinary Therapeutics in Dogs and Cats: A Species-Aware Framework for Comparative Oncology. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41900948 | PubMed |
| 41681415 | Band Neutrophils Are Observed in Dogs Undergoing Multiagent Chemotherapy Including Vincristine. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/41681415 | PubMed |
| 41069577 | Comparison of interpatient and intrapatient variability in doxorubicin exposure using a validated limited sampling model in dogs with cancer. | Vet Oncol | 2025 | https://conductscience.org/library/papers/41069577 | PubMed |
| 40671828 | Evaluation of the efficacy of icariin against heat stress-induced spermatogenic dysfunction in the testes of dogs. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40671828 | PubMed |
| 40574490 | Longitudinal Assessment of QT Apex in Tumor-Bearing Dogs Receiving Doxorubicin Monotherapy. | J Vet Intern Med | 2025 | https://conductscience.org/library/papers/40574490 | PubMed |
| 40370992 | Simultaneous, Seconds-Resolved Doxorubicin Measurements in the Blood and Subcutaneous Interstitial Fluid Identify Quantitative Pharmacokinetic Relationships between the Two. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40370992 | PubMed |
| 39716213 | Population pharmacokinetics modelling for clinical dose adjustment of carboplatin in dogs. | BMC Vet Res | 2024 | https://conductscience.org/library/papers/39716213 | PubMed |
| 38563346 | Vincristine-induced adverse events related to body weight in dogs treated for lymphoma. | J Vet Intern Med | 2024 | https://conductscience.org/library/papers/38563346 | PubMed |
| 37787577 | Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma. | J Vet Intern Med | 2023 | https://conductscience.org/library/papers/37787577 | PubMed |
| 36057542 | Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high-grade multicentric lymphoma. | Vet Comp Oncol | 2023 | https://conductscience.org/library/papers/36057542 | PubMed |
| 35524687 | Evaluation of adverse events in small-breed dogs treated with maropitant and a single dose of doxorubicin. | J Vet Intern Med | 2022 | https://conductscience.org/library/papers/35524687 | PubMed |
| 34825413 | Toxicity, outcome, and management of anthracycline overdoses in 16 dogs. | J Vet Intern Med | 2022 | https://conductscience.org/library/papers/34825413 | PubMed |
| 34263337 | Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma. | Cancer Chemother Pharmacol | 2021 | https://conductscience.org/library/papers/34263337 | PubMed |
| 30835925 | Use of computed tomography and radiation therapy planning software to develop a novel formula for body surface area calculation in dogs. | J Vet Intern Med | 2019 | https://conductscience.org/library/papers/30835925 | PubMed |
| 30638304 | Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers. | Vet Comp Oncol | 2019 | https://conductscience.org/library/papers/30638304 | PubMed |
| 29067202 | Tolerability of a rapid-escalation vinblastine-prednisolone protocol in dogs with mast cell tumours. | Vet Med Sci | 2016 | https://conductscience.org/library/papers/29067202 | PubMed |
| 27376143 | A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma. | Bladder Cancer | 2016 | https://conductscience.org/library/papers/27376143 | PubMed |
| 26933263 | Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma. | Can Vet J | 2016 | https://conductscience.org/library/papers/26933263 | PubMed |
| 26056373 | Species differences in tumour responses to cancer chemotherapy. | Philos Trans R Soc Lond B Biol Sci | 2015 | https://conductscience.org/library/papers/26056373 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7879983
GET https://conductscience.org/api/papers/v1/7879983/cited_by?page=2